112 related articles for article (PubMed ID: 3897932)
1. Effect of administration of BCG, levamisole and irradiated leukemic cells on immune status and remission status in chronic myelogenous leukemia.
Advani SH; Gulwani B; Ghogale SG; Shetye MR; Gangal SG
Oncology; 1985; 42(5):275-81. PubMed ID: 3897932
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of human malignant melanoma with irradiated tumor cells, oral Bacillus Calmette-Guérin, and levamisole.
Shibata HR; Jerry LM; Lewis MG; Mansell PW; Capek A; Marquis G
Ann N Y Acad Sci; 1976; 277(00):355-66. PubMed ID: 1069555
[No Abstract] [Full Text] [Related]
3. Effects of Bacillus Calmette-Guérin and levamisole on immune responses in young adult and age-immunodepressed mice.
Bruley-Rosset M; Florentin I; Kiger N; Davigny M; Mathé G
Cancer Treat Rep; 1978 Nov; 62(11):1641-50. PubMed ID: 728893
[TBL] [Abstract][Full Text] [Related]
4. Preliminary results of combined surgery and adjuvant Bacillus Calmette-Guérin plus levamisole treatment of resectable lung cancer.
Wright PW; Hill LD; Peterson AV; Pinkham R; Johnson L; Ivey T; Bernstein I; Bagley C; Anderson R
Cancer Treat Rep; 1978 Nov; 62(11):1671-5. PubMed ID: 215304
[TBL] [Abstract][Full Text] [Related]
5. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
Olkowski ZL; McLaren JR; Skeen MJ
Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy with irradiated autologous leukemic cells in patients with B-CLL in early stages.
Hus I; Kawiak J; Tabarkiewicz J; Radej S; Hoser G; Bojarska-Junak A; Schmitt M; Giannopoulos K; Dmoszynska A; Rolinski J
Oncol Rep; 2008 Aug; 20(2):443-51. PubMed ID: 18636210
[TBL] [Abstract][Full Text] [Related]
7. Preliminary evaluation of immunotherapy in patients with Hodgkin's disease.
Zywicka-Lopaciuk H; Konopka L; Karpowicz M; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Małkowska-Zwierz W; Pawelski S
Arch Immunol Ther Exp (Warsz); 1981; 29(6):739-55. PubMed ID: 7349093
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of chronic myelocytic leukemia: effects of different vaccination schedules.
Sokal JE; Aungst CW; Snyderman M; Gomez G
Ann N Y Acad Sci; 1976; 277(00):367-83. PubMed ID: 1069556
[TBL] [Abstract][Full Text] [Related]
9. Clinical studies of methanol extraction residue fraction of Bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancer.
Moertel CG; Ritts RE; Schutt AJ; Hahn RG
Cancer Res; 1975 Nov; 35(11 Pt 1):3075-83. PubMed ID: 1102082
[TBL] [Abstract][Full Text] [Related]
10. Intralesional treatment of recurrent metastatic cutaneous malignant melanoma: a randomized prospective study of intralesional Bacillus Calmette-Guerin versus intralesional dinitrochlorobenzene.
Cohen MH; Jessup JM; Felix EL; Weese JL; Herberman RB
Cancer; 1978 Jun; 41(6):2456-63. PubMed ID: 657108
[TBL] [Abstract][Full Text] [Related]
11. Levamisole in the treatment of non-invasive and invasive bladder cancer: a preliminary report.
Smith RB; Dekernion J; Baron B; Skinner DG; Kaufman JJ
J Urol; 1978 Mar; 119(3):347-9. PubMed ID: 347106
[TBL] [Abstract][Full Text] [Related]
12. Antibody responses to leukemia-associated antigens during immunotherapy of chronic myelocytic leukemia.
Ramachandar K; Baker MA; Taub RN
Blood; 1975 Dec; 46(6):845-54. PubMed ID: 1060471
[TBL] [Abstract][Full Text] [Related]
13. [Immunological status and surgery of cancer of the lung. Prognostic aspects and therapeutic prospects].
Fegiz G; Di Paola M; Colizza S
Minerva Chir; 1977 Jun; 32(11):677-82. PubMed ID: 329159
[No Abstract] [Full Text] [Related]
14. Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group.
Quirt IC; Shelley WE; Pater JL; Bodurtha AJ; McCulloch PB; McPherson TA; Paterson AH; Prentice R; Silver HK; Willan AR
J Clin Oncol; 1991 May; 9(5):729-35. PubMed ID: 2016615
[TBL] [Abstract][Full Text] [Related]
15. Leishmania mexicana in C3H mice: BCG and levamisole treatment of established infections.
Grimaldi GF; Moriearty PL; Hoff R
Clin Exp Immunol; 1980 Aug; 41(2):237-42. PubMed ID: 7438553
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy in the management of myelogenous leukemia.
Fairley GH
Arch Intern Med; 1976 Dec; 136(12):1406-12. PubMed ID: 793553
[TBL] [Abstract][Full Text] [Related]
17. BCG as adjuvant immunotherapy for neoplasia.
Hersh EM; Gutterman JU; Mavligit GM
Annu Rev Med; 1977; 28():489-515. PubMed ID: 324372
[No Abstract] [Full Text] [Related]
18. Response of disseminated breast cancer to combined modality treatment with chemotherapy and levamisole with or without Bacillus Calmette-Guérin.
Hortobagyi GN; Yap HY; Blumenschein GR; Gutterman JU; Buzdar AU; Tashima CK; Hersh EM
Cancer Treat Rep; 1978 Nov; 62(11):1685-92. PubMed ID: 728894
[TBL] [Abstract][Full Text] [Related]
19. Preliminary report of the use of levamisole in the treatment of bladder cancer.
Smith RB; deKernion J; Lincoln B; Skinner DG; Kaufman JJ
Cancer Treat Rep; 1978 Nov; 62(11):1709-14. PubMed ID: 365325
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of recurrent herpes simplex and its surveillance by MIF determination: with levamisole, BCG, urushiol and herpes antigen vaccine (author's transl)].
Jarisch R; Sandor I
Arch Dermatol Res (1975); 1977 Apr; 258(2):151-9. PubMed ID: 141241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
